CN Patent

CN112472814A — 神经活性类固醇制剂和治疗中枢神经系统障碍的方法

Assigned to Sage Therapeutics Inc · Expires 2021-03-12 · 5y expired

What this patent protects

包含神经活性类固醇(如异孕烷醇酮)和任选地环糊精(包括β‑环糊精如磺基丁基醚β‑环糊精(CAPTISOL))的制剂。以及使用所述神经活性类固醇制剂治疗中枢神经系统障碍(例如外伤性脑损伤、癫痫持续状态和癫痫发作)的方法。

USPTO Abstract

包含神经活性类固醇(如异孕烷醇酮)和任选地环糊精(包括β‑环糊精如磺基丁基醚β‑环糊精(CAPTISOL))的制剂。以及使用所述神经活性类固醇制剂治疗中枢神经系统障碍(例如外伤性脑损伤、癫痫持续状态和癫痫发作)的方法。

Drugs covered by this patent

Patent Metadata

Patent number
CN112472814A
Jurisdiction
CN
Classification
—
Expires
2021-03-12
Drug substance claim
No
Drug product claim
No
Assignee
Sage Therapeutics Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.